Table 1.
Prevalence of COVID-19 based on the type of rheumatic disease.
| Type of Disease | Condition | Coronavirus | Total | OR (95%CI) | P Value | |
|---|---|---|---|---|---|---|
| positive | negative | |||||
| SLE | Yes | 12(20%) | 110(16.2%) | 122 | 1.298(0.668–2.523) | 0.441 |
| No | 48(80%) | 571(83.8%) | 619(83.5%) | |||
| SPA | yes | 3(5%) | 119(17.4%) | 122(16.4%) | 0.249(0.077–0.810) | 0.013 |
| No | 57(95.0%) | 564(82.6%) | 621(83.6%) | |||
| SSC | yes | 11(18.3%) | 88(12.9%) | 99(13.4%) | 1.513(0.758–3.020) | 0.238 |
| No | 49(81.7%) | 595(87.1%) | 642(86.6%) | |||
| RA | yes | 22(36.7%) | 236(34.6%) | 258(34.7%) | 1.097(0.634–1.897) | 0.742 |
| No | 38(63.3%) | 447(65.4%) | 485(65.3%) | |||
| Sjogren | yes | 5(8.3%) | 41(6.0%) | 46(6.2%) | 1.424(0.540–3.749) | 0.743 |
| No | 55(91.7%) | 642(94.0%) | 697(93.8%) | |||
| GPA | yes | 1(1.7%) | 15(2.2%) | 16(2.2%) | 0.755(0.098–5.815) | 0.786 |
| No | 59(98.3%) | 668(97.8%) | 727(97.8%) | |||
| Takayasu | yes | 3(5%) | 35(5.1%) | 38(5.1%) | 0.974(0.291–3.267) | 0.967 |
| No | 57(95.0%) | 648(94.9%) | 705(94.9%) | |||
| Sarcoidosis | yes | 3(5%) | 16(2.3%) | 19(2.6%) | 2.194(0.621–7.754) | 0.211 |
| No | ||||||
OR: Odds ratio; CI: Confidence interval; SLE: Systemic Lupus Erythematosus; SPA: Spondyloarthropathy; SSC: Systemic sclerosis; RA: Rheumatoid Arthritis; GPA: Granulomatosis with polyangiitis.